Skip to main content
Erschienen in: Urolithiasis 5/2011

01.10.2011 | Original Paper

Cooperation of phosphates and carboxylates controls calcium oxalate crystallization in ultrafiltered urine

verfasst von: Bernd Grohe, Brian P. H. Chan, Esben S. Sørensen, Gilles Lajoie, Harvey A. Goldberg, Graeme K. Hunter

Erschienen in: Urolithiasis | Ausgabe 5/2011

Einloggen, um Zugang zu erhalten

Abstract

Osteopontin (OPN) is one of a group of proteins found in urine that are believed to limit the formation of kidney stones. In the present study, we investigate the roles of phosphate and carboxylate groups in the OPN-mediated modulation of calcium oxalate (CaOx), the principal mineral phase found in kidney stones. To this end, crystallization was induced by addition of CaOx solution to ultrafiltered human urine containing either human kidney OPN (kOPN; 7 consecutive carboxylates, 8 phosphates) or synthesized peptides corresponding to residues 65–80 (pSHDHMDDDDDDDDDGD; pOPAR) or 220–235 (pSHEpSTEQSDAIDpSAEK; P3) of rat bone OPN. Sequence 65–80 was also synthesized without the phosphate group (OPAR). Effects on calcium oxalate monohydrate (COM) and dihydrate (COD) formation were studied by scanning electron microscopy. We found that controls form large, partly intergrown COM platelets; COD was never observed. Adding any of the polyelectrolytes was sufficient to prevent intergrowth of COM platelets entirely, inhibiting formation of these platelets strongly, and inducing formation of the COD phase. Strongest effects on COM formation were found for pOPAR and OPAR followed by kOPN and then P3, showing that acidity and hydrophilicity are crucial in polyelectrolyte-affected COM crystallization. At higher concentrations, OPAR also inhibited COD formation, while P3, kOPN and, in particular, pOPAR promoted COD, a difference explainable by the variations of carboxylate and phosphate groups present in the molecules. Thus, we conclude that carboxylate groups play a primary role in inhibiting COM formation, but phosphate and carboxylate groups are both important in initiating and promoting COD formation.
Literatur
1.
Zurück zum Zitat Coe FL, Parks JH (1988) Nephrolithiasis: pathogenesis and treatment. Year Book Medical, Chicago, IL, pp 1–37 Coe FL, Parks JH (1988) Nephrolithiasis: pathogenesis and treatment. Year Book Medical, Chicago, IL, pp 1–37
2.
3.
Zurück zum Zitat Bushinsky DA (2001) Kidney stones. Adv Intern Med 47:219–238PubMed Bushinsky DA (2001) Kidney stones. Adv Intern Med 47:219–238PubMed
4.
Zurück zum Zitat Lieske JC, Toback FG (2000) Renal cell–urinary crystal interactions. Curr Opin Nephrol Hypertens 9:349–355PubMedCrossRef Lieske JC, Toback FG (2000) Renal cell–urinary crystal interactions. Curr Opin Nephrol Hypertens 9:349–355PubMedCrossRef
5.
6.
Zurück zum Zitat Mattle D, Hess B (2005) Preventive treatment of nephrolithiasis with alkali citrate—a critical review. Urol Res 33:73–79PubMedCrossRef Mattle D, Hess B (2005) Preventive treatment of nephrolithiasis with alkali citrate—a critical review. Urol Res 33:73–79PubMedCrossRef
7.
Zurück zum Zitat Ryall RL (2004) Macromolecules and urolithiasis: parallels and paradoxes. Nephron Physiol 98:37–42CrossRef Ryall RL (2004) Macromolecules and urolithiasis: parallels and paradoxes. Nephron Physiol 98:37–42CrossRef
8.
Zurück zum Zitat Kleinman JG, Wesson JA, Hughes J (2004) Osteopontin and calcium stone disease. Nephron Physiol 98:43–47CrossRef Kleinman JG, Wesson JA, Hughes J (2004) Osteopontin and calcium stone disease. Nephron Physiol 98:43–47CrossRef
10.
Zurück zum Zitat Shiraga HM, Min W VanDusen WJ, Clayman MD, Miner D, Terrell CH, Sherbotie JR, Foreman JW, Przysiecki C, Nielson EG, Hoyer JR (1992) Inhibition of calcium oxalate crystal growth in vitro by uropontin: another member of the aspartic acid-rich protein superfamily. Proc Natl Acad Sci USA 89:426–430 Shiraga HM, Min W VanDusen WJ, Clayman MD, Miner D, Terrell CH, Sherbotie JR, Foreman JW, Przysiecki C, Nielson EG, Hoyer JR (1992) Inhibition of calcium oxalate crystal growth in vitro by uropontin: another member of the aspartic acid-rich protein superfamily. Proc Natl Acad Sci USA 89:426–430
11.
Zurück zum Zitat Asplin JR, Arsenault D, Parks JH, Coe FL, Hoyer JR (1998) Contribution of human uropontin to inhibition of calcium oxalate crystallization. Kidney Int 53:194–199PubMedCrossRef Asplin JR, Arsenault D, Parks JH, Coe FL, Hoyer JR (1998) Contribution of human uropontin to inhibition of calcium oxalate crystallization. Kidney Int 53:194–199PubMedCrossRef
12.
Zurück zum Zitat Wesson JA, Worcester EM, Wiessner JH, Mandel NS, Kleinman JG (1998) Control of calcium oxalate crystal structure and cell adherence by urinary macromolecules. Kidney Int 53:952–957PubMedCrossRef Wesson JA, Worcester EM, Wiessner JH, Mandel NS, Kleinman JG (1998) Control of calcium oxalate crystal structure and cell adherence by urinary macromolecules. Kidney Int 53:952–957PubMedCrossRef
13.
Zurück zum Zitat Wang T, Thurgood LA, Grover PK, Ryall RL (2010) A comparison of the binding of urinary calcium oxalate monohydrate and dihydrate crystals to human kidney cells in urine. BJU Int 106(11):1768–1774PubMedCrossRef Wang T, Thurgood LA, Grover PK, Ryall RL (2010) A comparison of the binding of urinary calcium oxalate monohydrate and dihydrate crystals to human kidney cells in urine. BJU Int 106(11):1768–1774PubMedCrossRef
14.
Zurück zum Zitat Langdon A, Wignall GR, Rogers KA, Sørensen ES, Denstedt J, Grohe B, Goldberg HA, Hunter GK (2009) Kinetics of calcium oxalate crystal growth in the presence of osteopontin isoforms: an analysis by scanning confocal interference microcopy. Calcif Tissue Int 84:240–248PubMedCrossRef Langdon A, Wignall GR, Rogers KA, Sørensen ES, Denstedt J, Grohe B, Goldberg HA, Hunter GK (2009) Kinetics of calcium oxalate crystal growth in the presence of osteopontin isoforms: an analysis by scanning confocal interference microcopy. Calcif Tissue Int 84:240–248PubMedCrossRef
15.
Zurück zum Zitat Hoyer JR, Asplin JR, Otvos L (2001) Phosphorylated osteopontin peptides suppress crystallization by inhibiting the growth of calcium oxalate crystals. Kidney Int 60:77–82PubMedCrossRef Hoyer JR, Asplin JR, Otvos L (2001) Phosphorylated osteopontin peptides suppress crystallization by inhibiting the growth of calcium oxalate crystals. Kidney Int 60:77–82PubMedCrossRef
16.
Zurück zum Zitat Grohe B, O’Young J, Ionescu DA, Lajoie G, Rogers KA, Karttunen M, Goldberg HA, Hunter GK (2007) Control of calcium oxalate crystal growth by face-specific adsorption of an osteopontin phosphopeptide. J Am Chem Soc 129:14946–14951PubMedCrossRef Grohe B, O’Young J, Ionescu DA, Lajoie G, Rogers KA, Karttunen M, Goldberg HA, Hunter GK (2007) Control of calcium oxalate crystal growth by face-specific adsorption of an osteopontin phosphopeptide. J Am Chem Soc 129:14946–14951PubMedCrossRef
17.
Zurück zum Zitat Oldberg A, Franzen A, Heinegard D (1986) Cloning and sequence-analysis of rat bone sialoprotein (osteopontin) cDNA reveals an Arg-Gly-Asp cell-binding sequence. Proc Natl Acad Sci USA 83:8819–8823 Oldberg A, Franzen A, Heinegard D (1986) Cloning and sequence-analysis of rat bone sialoprotein (osteopontin) cDNA reveals an Arg-Gly-Asp cell-binding sequence. Proc Natl Acad Sci USA 83:8819–8823
18.
Zurück zum Zitat Grohe B, Taller A, Vincent PL, Tieu LD, Rogers KA, Heiss A, Sorensen ES, Mittler S, Goldberg HA, Hunter GK (2009) Crystallization of calcium oxalates is controlled by molecular hydrophilicity and specific polyanion–crystal interactions. Langmuir 25:11635–11646PubMedCrossRef Grohe B, Taller A, Vincent PL, Tieu LD, Rogers KA, Heiss A, Sorensen ES, Mittler S, Goldberg HA, Hunter GK (2009) Crystallization of calcium oxalates is controlled by molecular hydrophilicity and specific polyanion–crystal interactions. Langmuir 25:11635–11646PubMedCrossRef
19.
Zurück zum Zitat Jung T, Sheng XX, Choi CK, Kim WS, Wesson JA, Ward MD (2004) Probing crystallization of calcium oxalate monohydrate and the role of macromolecule additives with in situ atomic force microscopy. Langmuir 20:8587–8596PubMedCrossRef Jung T, Sheng XX, Choi CK, Kim WS, Wesson JA, Ward MD (2004) Probing crystallization of calcium oxalate monohydrate and the role of macromolecule additives with in situ atomic force microscopy. Langmuir 20:8587–8596PubMedCrossRef
20.
Zurück zum Zitat Taller A, Grohe B, Rogers KA, Goldberg HA, Hunter GK (2007) Specific adsorption of osteopontin and synthetic polypeptides to calcium oxalate monohydrate crystals. Biophys J 93:1768–1777PubMedCrossRef Taller A, Grohe B, Rogers KA, Goldberg HA, Hunter GK (2007) Specific adsorption of osteopontin and synthetic polypeptides to calcium oxalate monohydrate crystals. Biophys J 93:1768–1777PubMedCrossRef
21.
Zurück zum Zitat Keykhosravani M, Doherty-Kirby A, Zhang C, Brewer D, Goldberg HA, Hunter GK, Lajoie G (2005) Comprehensive identification of post-translational modifications of rat bone osteopontin by mass spectrometry. Biochemistry 44:6990–7003PubMedCrossRef Keykhosravani M, Doherty-Kirby A, Zhang C, Brewer D, Goldberg HA, Hunter GK, Lajoie G (2005) Comprehensive identification of post-translational modifications of rat bone osteopontin by mass spectrometry. Biochemistry 44:6990–7003PubMedCrossRef
22.
Zurück zum Zitat Doyle IR, Ryall RL, Marshall VR (1991) Inclusion of proteins into calcium-oxalate crystals precipitated from human urine—a highly selective phenomenon. Clin Chem 37:1589–1594PubMed Doyle IR, Ryall RL, Marshall VR (1991) Inclusion of proteins into calcium-oxalate crystals precipitated from human urine—a highly selective phenomenon. Clin Chem 37:1589–1594PubMed
23.
Zurück zum Zitat Christensen B, Petersen TE, Sorensen ES (2008) Post-translational modification and proteolytic processing of urinary osteopontin. Biochem J 411:53–61PubMedCrossRef Christensen B, Petersen TE, Sorensen ES (2008) Post-translational modification and proteolytic processing of urinary osteopontin. Biochem J 411:53–61PubMedCrossRef
24.
Zurück zum Zitat Taylor EN, Curhan GC (2006) Body size and 24-hour urine composition. Am J Kidney Dis 48:905–915PubMedCrossRef Taylor EN, Curhan GC (2006) Body size and 24-hour urine composition. Am J Kidney Dis 48:905–915PubMedCrossRef
25.
Zurück zum Zitat Whitson JM, Cooperberg MR, Stackhouse GB, Stoller ML (2007) Urinary citrate levels do not correlate with urinary pH in patients with urinary stone formation. Urology 70:634–637PubMedCrossRef Whitson JM, Cooperberg MR, Stackhouse GB, Stoller ML (2007) Urinary citrate levels do not correlate with urinary pH in patients with urinary stone formation. Urology 70:634–637PubMedCrossRef
26.
Zurück zum Zitat Grohe B, Rogers KA, Goldberg HA, Hunter GK (2006) Crystallization kinetics of calcium oxalate hydrates studied by scanning confocal interference microscopy. J Cryst Growth 295:148–157CrossRef Grohe B, Rogers KA, Goldberg HA, Hunter GK (2006) Crystallization kinetics of calcium oxalate hydrates studied by scanning confocal interference microscopy. J Cryst Growth 295:148–157CrossRef
27.
Zurück zum Zitat Millan A (2001) Crystal growth shape of whewellite polymorphs: influence of structure distortions on crystal shape. Cryst Growth Des 1:245–254CrossRef Millan A (2001) Crystal growth shape of whewellite polymorphs: influence of structure distortions on crystal shape. Cryst Growth Des 1:245–254CrossRef
28.
Zurück zum Zitat Shirane Y, Kagawa S (1993) Scanning electron-microscopic study of the effect of citrate and pyrophosphate on calcium-oxalate crystal morphology. J Urol 150:1980–1983PubMed Shirane Y, Kagawa S (1993) Scanning electron-microscopic study of the effect of citrate and pyrophosphate on calcium-oxalate crystal morphology. J Urol 150:1980–1983PubMed
29.
Zurück zum Zitat Werness PG, Bergert JH, Smith LH (1981) Crystalluria. J Cryst Growth 53:166–181CrossRef Werness PG, Bergert JH, Smith LH (1981) Crystalluria. J Cryst Growth 53:166–181CrossRef
30.
Zurück zum Zitat Iwata H, Iio S, Nishio S, Takeuchi M (1992) Architecture of mixed calcium-oxalate dihydrate and monohydrate stones. Scanning Microsc 6:231–238PubMed Iwata H, Iio S, Nishio S, Takeuchi M (1992) Architecture of mixed calcium-oxalate dihydrate and monohydrate stones. Scanning Microsc 6:231–238PubMed
31.
Zurück zum Zitat Lieske JC, Toback FG, Deganello S (2001) Sialic acid-containing glycoproteins on renal cells determine nucleation of calcium oxalate dihydrate crystals. Kidney Int 60:1784–1791PubMedCrossRef Lieske JC, Toback FG, Deganello S (2001) Sialic acid-containing glycoproteins on renal cells determine nucleation of calcium oxalate dihydrate crystals. Kidney Int 60:1784–1791PubMedCrossRef
33.
Zurück zum Zitat Pak CYC, Adams-Huet B (2004) Elucidation of factors determining formation of calcium phosphate stones. J Urol 172:2267–2270PubMedCrossRef Pak CYC, Adams-Huet B (2004) Elucidation of factors determining formation of calcium phosphate stones. J Urol 172:2267–2270PubMedCrossRef
34.
Zurück zum Zitat Königsberger E, Königsberger L-C (2001) Thermodynamic modeling of crystal deposition in humans. J Pure Appl Chem 73:785–797CrossRef Königsberger E, Königsberger L-C (2001) Thermodynamic modeling of crystal deposition in humans. J Pure Appl Chem 73:785–797CrossRef
35.
Zurück zum Zitat Debye P, Hückel E (1923) The theory of electrolytes. I. Lowering of freezing point and related phenomena. Physikalische Zeitschrift 24:185–206 Debye P, Hückel E (1923) The theory of electrolytes. I. Lowering of freezing point and related phenomena. Physikalische Zeitschrift 24:185–206
36.
Zurück zum Zitat Davis CW (1962) Ion association. Butterworth, London Davis CW (1962) Ion association. Butterworth, London
37.
Zurück zum Zitat Daudon M, Bazin D, Andre G, Jungers P, Cousson A, Chevallier P, Vernon E, Matzen G (2009) Examination of whewellite kidney stones by scanning electron microscopy and powder neutron diffraction techniques. J Appl Crystallogr 42:109–115CrossRef Daudon M, Bazin D, Andre G, Jungers P, Cousson A, Chevallier P, Vernon E, Matzen G (2009) Examination of whewellite kidney stones by scanning electron microscopy and powder neutron diffraction techniques. J Appl Crystallogr 42:109–115CrossRef
38.
Zurück zum Zitat Fernandez JC, Delasnieves FJ, Salcedo JS, Hidalgoalvarez R (1990) The microelectrophoretic mobility and colloid stability of calcium-oxalate monohydrate dispersions in aqueous-media. J Colloid Interf Sci 135:154–164CrossRef Fernandez JC, Delasnieves FJ, Salcedo JS, Hidalgoalvarez R (1990) The microelectrophoretic mobility and colloid stability of calcium-oxalate monohydrate dispersions in aqueous-media. J Colloid Interf Sci 135:154–164CrossRef
39.
Zurück zum Zitat Sandersius S, Rez P (2007) Morphology of crystals in calcium oxalate monohydrate kidney stones. Urol Res 35:287–293PubMedCrossRef Sandersius S, Rez P (2007) Morphology of crystals in calcium oxalate monohydrate kidney stones. Urol Res 35:287–293PubMedCrossRef
40.
Zurück zum Zitat Kile DE, Eberl DD (2003) On the origin of size-dependent and size-independent crystal growth: influence of advection and diffusion. Am Mineral 88:1514–1521 Kile DE, Eberl DD (2003) On the origin of size-dependent and size-independent crystal growth: influence of advection and diffusion. Am Mineral 88:1514–1521
41.
Zurück zum Zitat Zauner R, Jones AG (2000) Determination of nucleation, growth, agglomeration and disruption kinetics from experimental precipitation data: the calcium oxalate system. Chem Eng Sci 55:4219–4232CrossRef Zauner R, Jones AG (2000) Determination of nucleation, growth, agglomeration and disruption kinetics from experimental precipitation data: the calcium oxalate system. Chem Eng Sci 55:4219–4232CrossRef
42.
Zurück zum Zitat Wesson JA, Ganne V, Beshensky AM, Kleinman JG (2005) Regulation by macromolecules of calcium oxalate crystal aggregation in stone formers. Urol Res 33:206–212PubMedCrossRef Wesson JA, Ganne V, Beshensky AM, Kleinman JG (2005) Regulation by macromolecules of calcium oxalate crystal aggregation in stone formers. Urol Res 33:206–212PubMedCrossRef
43.
Zurück zum Zitat McCabe WL (1929) Crystal growth in aqueous solutions. Ind Eng Chem 21:30–33CrossRef McCabe WL (1929) Crystal growth in aqueous solutions. Ind Eng Chem 21:30–33CrossRef
44.
Zurück zum Zitat Min W, Shiraga H, Chalko C, Goldfarb S, Krishna GG, Hoyer JR (1998) Quantitative studies of human urinary excretion of uropontin. Kidney Int 53:189–193PubMedCrossRef Min W, Shiraga H, Chalko C, Goldfarb S, Krishna GG, Hoyer JR (1998) Quantitative studies of human urinary excretion of uropontin. Kidney Int 53:189–193PubMedCrossRef
45.
Zurück zum Zitat Qiu SR, Wierzbicki A, Salter EA, Zepeda S, Orme CA, Hoyer JR, Nancollas GH, Cody AM, De Yoreo JJ (2005) Modulation of calcium oxalate monohydrate crystallization by citrate through selective binding to atomic steps. J Am Chem Soc 127:9036–9044PubMedCrossRef Qiu SR, Wierzbicki A, Salter EA, Zepeda S, Orme CA, Hoyer JR, Nancollas GH, Cody AM, De Yoreo JJ (2005) Modulation of calcium oxalate monohydrate crystallization by citrate through selective binding to atomic steps. J Am Chem Soc 127:9036–9044PubMedCrossRef
46.
Zurück zum Zitat Wignall GR, Langdon AN, Grohe B, Goldberg HA, Denstedt JD, Hunter GK (2008) Inhibited growth of calcium oxalate monohydrate in the presence of osteopontin and synthetic phosphopeptides. J Urol 179:565–566CrossRef Wignall GR, Langdon AN, Grohe B, Goldberg HA, Denstedt JD, Hunter GK (2008) Inhibited growth of calcium oxalate monohydrate in the presence of osteopontin and synthetic phosphopeptides. J Urol 179:565–566CrossRef
47.
Zurück zum Zitat Sikiric M, Filipovic-Vincekovic N, Babic-Ivancic V, Vdovic N, Furedi-Milhofer H (1999) Interactions in calcium oxalate hydrate surfactant systems. J Colloid Interf Sci 212:384–389CrossRef Sikiric M, Filipovic-Vincekovic N, Babic-Ivancic V, Vdovic N, Furedi-Milhofer H (1999) Interactions in calcium oxalate hydrate surfactant systems. J Colloid Interf Sci 212:384–389CrossRef
48.
Zurück zum Zitat Verkoelen CF, van der Boom BG, Kok DJ, Romijn JC (2000) Sialic acid and crystal binding. Kidney Int 57:1072–1082PubMedCrossRef Verkoelen CF, van der Boom BG, Kok DJ, Romijn JC (2000) Sialic acid and crystal binding. Kidney Int 57:1072–1082PubMedCrossRef
49.
Zurück zum Zitat Hunter GK, Grohe B, Jeffrey S, O’Young J, Sørensen ES, Goldberg HA (2009) Role of phosphate groups in inhibition of calcium oxalate crystal growth by osteopontin. Cells Tissues Organs 189:44–50PubMedCrossRef Hunter GK, Grohe B, Jeffrey S, O’Young J, Sørensen ES, Goldberg HA (2009) Role of phosphate groups in inhibition of calcium oxalate crystal growth by osteopontin. Cells Tissues Organs 189:44–50PubMedCrossRef
50.
Zurück zum Zitat Weaver ML, Qiu SR, Hoyer JR, Casey WH, Nancollas GH, De Yoreo JJ (2009) Surface aggregation of urinary proteins and aspartic acid-rich peptides on the faces of calcium oxalate monohydrate investigated by in situ force microscopy. Calcif Tissue Int 84:462–473PubMedCrossRef Weaver ML, Qiu SR, Hoyer JR, Casey WH, Nancollas GH, De Yoreo JJ (2009) Surface aggregation of urinary proteins and aspartic acid-rich peptides on the faces of calcium oxalate monohydrate investigated by in situ force microscopy. Calcif Tissue Int 84:462–473PubMedCrossRef
51.
Zurück zum Zitat Philipse A (2005) Particulate colloids: aspects of preparation and characterization. Elsevier, Amsterdam Philipse A (2005) Particulate colloids: aspects of preparation and characterization. Elsevier, Amsterdam
52.
Zurück zum Zitat Zappone B, Thurner PJ, Adams J, Fantner GE, Hansma PK (2008) Effect of Ca2+ ions on the adhesion and mechanical properties of adsorbed layers of human osteopontin. Biophys J 95:2939–2950PubMedCrossRef Zappone B, Thurner PJ, Adams J, Fantner GE, Hansma PK (2008) Effect of Ca2+ ions on the adhesion and mechanical properties of adsorbed layers of human osteopontin. Biophys J 95:2939–2950PubMedCrossRef
53.
Zurück zum Zitat Heijnen WMM, Vanduijneveldt FB (1984) The theoretical growth-morphology of calcium-oxalate dihydrate. J Cryst Growth 67:324–336CrossRef Heijnen WMM, Vanduijneveldt FB (1984) The theoretical growth-morphology of calcium-oxalate dihydrate. J Cryst Growth 67:324–336CrossRef
54.
Zurück zum Zitat Chien YC, Masica DL, Gray JJ, Nguyen S, Vali H, Mckee MD (2009) Modulation of calcium oxalate dihydrate growth by selective crystal-face binding of phosphorylated osteopontin and polyaspartate peptide showing occlusion by sectoral (compositional) zoning. J Biol Chem 284:23491–23501PubMedCrossRef Chien YC, Masica DL, Gray JJ, Nguyen S, Vali H, Mckee MD (2009) Modulation of calcium oxalate dihydrate growth by selective crystal-face binding of phosphorylated osteopontin and polyaspartate peptide showing occlusion by sectoral (compositional) zoning. J Biol Chem 284:23491–23501PubMedCrossRef
55.
Zurück zum Zitat Addadi L, Moradian J, Shay E, Maroudas NG, Weiner S (1987) A chemical-model for the cooperation of sulfates and carboxylates in calcite crystal nucleation—relevance to biomineralization. Proc Natl Acad Sci USA 84:2732–2736 Addadi L, Moradian J, Shay E, Maroudas NG, Weiner S (1987) A chemical-model for the cooperation of sulfates and carboxylates in calcite crystal nucleation—relevance to biomineralization. Proc Natl Acad Sci USA 84:2732–2736
Metadaten
Titel
Cooperation of phosphates and carboxylates controls calcium oxalate crystallization in ultrafiltered urine
verfasst von
Bernd Grohe
Brian P. H. Chan
Esben S. Sørensen
Gilles Lajoie
Harvey A. Goldberg
Graeme K. Hunter
Publikationsdatum
01.10.2011
Verlag
Springer-Verlag
Erschienen in
Urolithiasis / Ausgabe 5/2011
Print ISSN: 2194-7228
Elektronische ISSN: 2194-7236
DOI
https://doi.org/10.1007/s00240-010-0360-8

Weitere Artikel der Ausgabe 5/2011

Urolithiasis 5/2011 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

Stufenschema weist Prostatakarzinom zuverlässig nach

22.04.2024 Prostatakarzinom Nachrichten

Erst PSA-Test, dann Kallikrein-Score, schließlich MRT und Biopsie – ein vierstufiges Screening-Schema kann die Zahl der unnötigen Prostatabiopsien erheblich reduzieren: Die Hälfte der Männer, die in einer finnischen Studie eine Biopsie benötigten, hatte einen hochgradigen Tumor.

Harnwegsinfektprophylaxe: Es geht auch ohne Antibiotika

20.04.2024 EAU 2024 Kongressbericht

Beim chronischen Harnwegsinfekt bei Frauen wird bisher meist eine Antibiotikaprophylaxe eingesetzt. Angesichts der zunehmenden Antibiotikaresistenz erweist sich das Antiseptikum Methenamin-Hippurat als vielversprechende Alternative, so die Auswertung einer randomisierten kontrollierten Studie.

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.